A member of our corporate communications team, Shakyia Grooms, HMCC, received the Dayna Brunnelli Tomorrow’s Leader Award from MPI New England. Nominated by her peers, this award recognizes individuals early in their careers who have made significant contributions to the association and events industry. She particularly brings events to life in collaboration with our global employee resource networks. Congratulations Shakyia, we’re excited to see how your leadership continues to shape the future!
Vertex Pharmaceuticals
Biotechnology Research
Boston, MA 410,381 followers
The Science of Possibility
About us
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
- Website
-
https://www.vrtx.com/
External link for Vertex Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 1989
- Specialties
- cystic fibrosis, alpha-1 antitrypsin deficiency (AATD), APOL1-mediated kidney diseases, sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, and type 1 diabetes mellitus
Locations
Employees at Vertex Pharmaceuticals
Updates
-
When a routine call turned into a mayday situation, firefighter Cody Burton’s knowledge of the complexities of pain management became even more important. Hear how Cody navigated weeks of severe pain following his injury and why being prepared to discuss pain management with your doctor can be crucial: https://lnkd.in/ePFSqSDt
-
The Vertex Foundation Scholarship Program application is open! If you are living with cystic fibrosis or are an immediate family member or caregiver of someone living with the disease, the Vertex Foundation Scholarship Program is here to support you as you pursue a two-year, three-year, four-year or graduate degree. Apply now: https://lnkd.in/e5Me_MZ2
-
Sharron’s “whole life changed in a moment” when she found out she had a form of APOL1-mediated kidney disease (AMKD). We’re honored that her inspiring story of family and self-advocacy has been selected as a finalist in the International Society of Nephrology Community Film Event. Help us celebrate her powerful story by casting your vote for “Best Community Film”: https://lnkd.in/gAEfBwxh
-
Pushing the boundaries of innovation requires a culture where inclusion is embraced, diversity is celebrated, and everyone belongs. We’re honored to be recognized once again with the Human Rights Campaign Foundation’s 2025 Equality 100 Award for earning a top score on this year’s Corporate Equality Index. This achievement underscores our longstanding commitment to inclusion, diversity and equity (ID&E) and our unwavering support for LGBTQ+ equality and inclusion. #CEI2025
-
Calling early career physician-scientists! Don’t miss the opportunity to join our Vertex Physician Investigator program where you will gain a broad understanding of the drug development process through immersive rotations and mentorships. Learn more and apply by January 10: https://lnkd.in/g_-AUybx
-
Innovative breakthroughs in drug discovery don’t happen alone. Turn your ideas into action. As a Vertex Fellow, you will have access to mentorship and work with leaders across the company. Learn more and apply now: https://lnkd.in/eNsYGBQj
-
For over two decades, our teams have pushed the boundaries of what’s possible in cystic fibrosis (CF) research. Fred Van Goor, VP of CF Research, shares our journey to tackle the “fantasy project” of CF, from reimagining molecular treatments to transforming hope into reality. Read more: https://lnkd.in/eHsVd46Z
-
At Vertex, helping patients isn’t just part of our work—it’s our top priority. Senior Director Mark Higgins shares how our cystic fibrosis (CF) clinical trials start with patients in mind, bringing together scientists from across fields to help address unmet needs in CF care. https://lnkd.in/e-rs7pfV
Taking a patient-first approach to clinical trials
-
Another important step in bringing our CF therapies to as many patients around the world as possible: We’re pleased to announce the extension of a reimbursement agreement #Romania with the National Health Insurance to cover eligible children living with CF ages 2 years and older. The new agreement has been active from the beginning of December.
Similar pages
Browse jobs
Stock
VRTX
NASDAQ
20 minutes delay
$422.00
5.04 (1.209%)
- Open
- 422.73
- Low
- 419.27
- High
- 428.25
Data from Refinitiv
See more info on